Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
WuXi Biologics (Cayman) Inc. 2269.HK
$46.05
-$0.54 (-1.18%)
На 18:03, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
190347964442.00000000
-
week52high
87.00
-
week52low
35.00
-
Revenue
15268660000
-
P/E TTM
39
-
Beta
1.17786200
-
EPS
1.05000000
-
Last Dividend
0.00000000
-
Next Earnings Date
22 мар 2023 г. в 12:00
Описание компании
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии